Ocular Therapeutix shareholders approve doubling authorized shares to 400M and increasing equity plan by 7M shares

OCULAR THERAPEUTIX, INC

Stockholders approved amendment to increase authorized common stock from 200M to 400M shares.
Stockholders approved Amendment No. 3 to 2021 Stock Incentive Plan, adding 7M shares for issuance.
Elected Adrienne L. Graves, Ph.D. and Charles Warden as Class I directors for term ending 2027.
Ratified PricewaterhouseCoopers LLP as independent auditor for FY 2024; votes: 119.6M for, 0.86M against.
Non-binding advisory vote on executive compensation passed with 76.3M for, 9.3M against.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.